Skip to main content
. 2020 Apr 2;10(2):117–121. doi: 10.4103/ijabmr.IJABMR_349_18

Table 4.

Correlation between estrogen receptor and progesterone receptor status of metastatic lymph node with estrogen receptor and progesterone receptor status of primary tumor

Tumor mass Lymph node (%) χ2, P

ER+ and PR+ ER+ and PR− ER− and PR−
ER+ and PR+ 21 (35) 1 (1.67) 1 (1.67) 84.53, 0.0001 (significant)
ER+ and PR− 0 (0) 1 (1.67) 0 (0)
ER− and PR− 0 (0) 0 (0) 36 (60)
Total 21 (35) 2 (3.33) 37 (61.67)

ER: Estrogen receptor; PR: Progesterone receptor